Inozyme Pharma Announces Authorization to Proceed in U.S. and U.K. with Phase 1/2 Clinical Trial of INZ-701 for the Treatment of ENPP1 Deficiency by Seini Moimoi | Jan 4, 2021 | Portfolio News
Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team by Seini Moimoi | Jan 4, 2021 | Portfolio News
